zalcitabine has been researched along with Alzheimer Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Basile, L; Copani, A; Giuffrida, ML; Guccione, S; Merlo, S; Sortino, MA | 1 |
| He, M; Hu, D; Mao, L; Meng, L; Nie, S; Xiong, J; Xiong, M; Zhang, X; Zhang, Z | 1 |
2 other study(ies) available for zalcitabine and Alzheimer Disease
| Article | Year |
|---|---|
Identification of 5-Methoxyflavone as a Novel DNA Polymerase-Beta Inhibitor and Neuroprotective Agent against Beta-Amyloid Toxicity.
Topics: Alzheimer Disease; Cell Cycle; Cell Death; Cell Division; DNA Polymerase beta; DNA Replication; Enzyme Inhibitors; Flavones; Humans; Molecular Structure; Neurons; Neuroprotective Agents; Parkinson Disease | 2015 |
2',3'-Dideoxycytidine, a DNA Polymerase-β Inhibitor, Reverses Memory Deficits in a Mouse Model of Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; DNA Polymerase beta; DNA Replication; Enzyme Inhibitors; Maze Learning; Memory Disorders; Mice; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; Primary Cell Culture; Synapses; Zalcitabine | 2019 |